Purpose
to develop dimimeric IgA human monoclonal antibodies as passive therapy for HIV-1 prevention
Grantee
Division
Global Health
Date
MAY 2012
Region served
GLOBAL
Committed amount
$8,900,481
Grant topic
HIV
Duration (months)
44
Grantee location
Durham, North Carolina, United States
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.